Silver Grove Financial Group, Inc.

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 2111172 ORCHARD PARK, NY

Position in BTAI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$447

New position

Shares Held

334

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#26

of 40 holders

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 9.880239520958083.ToString("F0")% Shared 0.ToString("F0")% None 90.11976047904191.ToString("F0")%

Healthcare · as of Mar 31, 2026

Silver Grove Financial Group, Inc. holds $93,567 across 3 Drug Manufacturers - Specialty & Generic names. BTAI ranks #3 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	766	$90,548
2	HLN	Haleon plc	257	$2,572
3	BTAI	BioXcel Therapeutics, Inc. This page	334	$447

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$447	334	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.